Fennec Pharmaceuticals Inc. (FENC) stock
FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3088% above fair value
$13.58+0.82 (+6.43%)
Close on Nov 17, 2026Market cap $476.21MP/E –Yield –
Fennec Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Fennec Pharmaceuticals's total debt was $25.00M at Sep 30, 2022. For fiscal 2021 it was $5.00M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $5.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2022 | Sep 30, 2022 | $25.00M | – |
| Q2 FY2022 | Jun 30, 2022 | $5.00M | – |
| Q1 FY2022 | Mar 31, 2022 | $5.00M | – |
| Q4 FY2021 | Dec 31, 2021 | $5.00M | – |
See a number that looks wrong?